These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16050922)

  • 1. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services.
    Vos T; Haby MM; Magnus A; Mihalopoulos C; Andrews G; Carter R
    Aust N Z J Psychiatry; 2005 Aug; 39(8):701-12. PubMed ID: 16050924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand.
    Prukkanone B; Vos T; Bertram M; Lim S
    Value Health; 2012; 15(1 Suppl):S3-8. PubMed ID: 22265064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK.
    Koeser L; Donisi V; Goldberg DP; McCrone P
    Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of major depression avoidable by longer-term treatment strategies.
    Vos T; Haby MM; Barendregt JJ; Kruijshaar M; Corry J; Andrews G
    Arch Gen Psychiatry; 2004 Nov; 61(11):1097-103. PubMed ID: 15520357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents.
    Haby MM; Tonge B; Littlefield L; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):579-91. PubMed ID: 15298580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
    Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
    Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
    Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
    Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of cognitive behavioral therapy for bulimia nervosa in the Australian context.
    Le LK; Hay P; Wade T; Touyz S; Mihalopoulos C
    Int J Eat Disord; 2017 Dec; 50(12):1367-1377. PubMed ID: 29044626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
    Heuzenroeder L; Donnelly M; Haby MM; Mihalopoulos C; Rossell R; Carter R; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):602-12. PubMed ID: 15298582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression.
    Byford S; Barrett B; Roberts C; Wilkinson P; Dubicka B; Kelvin RG; White L; Ford C; Breen S; Goodyer I
    Br J Psychiatry; 2007 Dec; 191():521-7. PubMed ID: 18055956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Cost-Effectiveness--Mental Health: introduction to the study and methods.
    Haby MM; Carter R; Mihalopoulos C; Magnus A; Sanderson K; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):569-78. PubMed ID: 15298579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Katsuki F; Fujita H; Sasaki M; Sado M; Perlis ML
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):335-43. PubMed ID: 25205008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is implementation of the 2013 Australian treatment guidelines for posttraumatic stress disorder cost-effective compared to current practice? A cost-utility analysis using QALYs and DALYs.
    Mihalopoulos C; Magnus A; Lal A; Dell L; Forbes D; Phelps A
    Aust N Z J Psychiatry; 2015 Apr; 49(4):360-76. PubMed ID: 25348698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada.
    Myhr G; Payne K
    Can J Psychiatry; 2006 Sep; 51(10):662-70. PubMed ID: 17052034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing cost-effectiveness in mental health: family interventions for schizophrenia and related conditions.
    Mihalopoulos C; Magnus A; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Jul; 38(7):511-9. PubMed ID: 15255823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.